As compounded GLP-1 RAs continue to fill gaps caused by shortages or cost barriers, clinicians must exercise heightened vigilance, ensure use of reputable compounding sources, and provide robust patient education
Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntingtons disease
It may also increase low blood sugar risk when used with insulin or sulfonylureas
The peptides targeted action and ability to mimic natural GH release make it suitable for treatment plans intended for long term use
And in the case of the latest wave of weight loss drugs, right now at their current prices they are not even cost-effective, let alone cost-saving
The results appear to be consistent throughout the investigations, as indicated by the minimal heterogeneity (I 2 = 0.0%) as shown in Figure 7